Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/16/2008WO2008124187A1 Biochemical markers for disease states and genes for identification of biochemical defects
10/16/2008WO2008124109A2 System for pulling out regulatory elements using yeast
10/16/2008WO2008124107A1 Compositions, devices, systems, and methods for using a nanopore
10/16/2008WO2008124100A1 Prion elisa
10/16/2008WO2008124098A1 Prion assay
10/16/2008WO2008124096A1 Systems and methods for analyzing persistent homeostatic perturbations
10/16/2008WO2008124066A1 Agents that reduce neuronal overexcitation
10/16/2008WO2008124063A1 Method for performing correction of blood glucose assay bias using blood hemoglobin concentration and devices for same
10/16/2008WO2008124059A1 Carrying assembly with analyte-determining instrument
10/16/2008WO2008124055A1 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
10/16/2008WO2008124021A1 Method of detecting red cell antigen-antibody reactions
10/16/2008WO2008124010A1 Surfactant protein d is a biomarker for steroid responsiveness in asthma and chronic obstructive pulmonary disease
10/16/2008WO2008123948A1 Biomarkers for ovarian cancer
10/16/2008WO2008123887A1 Constitutively resistant cancer stem cells in diagnosis
10/16/2008WO2008123844A2 System for detecting nanoparticles using modulated surface plasmon resonance (mspr)
10/16/2008WO2008123831A1 Adapter, apparatus and method for exhaled breath measurements
10/16/2008WO2008123790A1 Oncological disease diagnosis method
10/16/2008WO2008123291A1 Labeling fluorescent compound
10/16/2008WO2008123266A1 Target protein and target gene for drug discovery, and screening method
10/16/2008WO2008123202A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR
10/16/2008WO2008123180A1 Method for detection of target substance, and tag, dna, vector, probe and detection kit for use in the method
10/16/2008WO2008123022A1 Liquid feeding apparatus and liquid feeding control method
10/16/2008WO2008122936A1 Methods and tools for discriminating colorectal adenomas and adenocarcinomas
10/16/2008WO2008122932A1 Air pollution sensor system
10/16/2008WO2008122806A1 Respiratory sensor
10/16/2008WO2008122805A1 Analysis method
10/16/2008WO2008122796A1 Assay device
10/16/2008WO2008122793A2 Blood group antibody screening
10/16/2008WO2008122676A1 Locking system for automobiles and other vehicles
10/16/2008WO2008122622A1 Device and method for analyzing a heterogeneous material by means of laser-induced plasma spectroscopy
10/16/2008WO2008122604A1 Method of crosslinking two objects of interest
10/16/2008WO2008122571A1 Device for measuring the movement of the regression surface of a burning optically transparent combustible material
10/16/2008WO2008122551A2 Anti-epcam antibody and uses thereof
10/16/2008WO2008122441A2 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/16/2008WO2008122432A1 Transglutaminase 6 as a diagnostic indicator of autoimmune diseases
10/16/2008WO2008122274A1 METHOD FOR ASSAYING PATHOLOGICALLY MODIFIED PRION PROTEIN (PrPSc)
10/16/2008WO2008122241A1 Rapid protein analyses and the device thereof
10/16/2008WO2008122088A1 Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex
10/16/2008WO2008104689A3 Device for monitoring the level of the condensate collected in the measuring cylinder of a standardized distillaton apparatus and method implemented by using this device
10/16/2008WO2008104685A3 Method for automatically distilling liquid specimens at atmospheric pressure in a standardized distillation apparatus
10/16/2008WO2008098106A3 Translational data mart
10/16/2008WO2008097892A3 Apparatus and methods for dispensing sample holders
10/16/2008WO2008097802A3 Epitope-mediated antigen prediction
10/16/2008WO2008097371A3 Modular microfluidic flow cytometer and method applications
10/16/2008WO2008096374A3 Markers for transformed epithelium and potential targets for therapy of cancer of the gingivo buccal complex
10/16/2008WO2008091583A3 Image-based extraction for vascular trees
10/16/2008WO2008091408A3 Circulating renalase and methods of increasing same
10/16/2008WO2008089756A3 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
10/16/2008WO2008089438A3 A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions
10/16/2008WO2008086452A3 Treatment and prevention of alzheimer's disease
10/16/2008WO2008085777A3 A method for early detection of cancer
10/16/2008WO2008080126A3 Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease
10/16/2008WO2008080031A9 Chromatographic test strips for one or more analytes
10/16/2008WO2008077147A3 Devices, systems, methods and tools for continuous glucose monitoring
10/16/2008WO2008077027A3 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders
10/16/2008WO2008073624A3 Quantitative nucleic acid hybridization using magnetic luminescent particles
10/16/2008WO2008073382A3 Hsp90 and ip6k2 binding
10/16/2008WO2008070676A9 Multiplex assay reader system
10/16/2008WO2008070586A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases
10/16/2008WO2008070236A3 Diagnostic assay for detecting and monitoring hearing loss
10/16/2008WO2008070229A3 Detection of pathogenic aggregates of protein in a sample by homologous elisa
10/16/2008WO2008066629A3 Methods for quantitative proteome analysis of glycoproteins
10/16/2008WO2008066596A3 Gene expression barcode for normal and diseased tissue classification
10/16/2008WO2008061214A9 Gas sensor with an analyte modulator
10/16/2008WO2008060899A3 Breast cancer screening and treatment methods
10/16/2008WO2008060896A3 Methods for identifying and analyzing biomarkers from plasma-derived microparticles
10/16/2008WO2008060784A3 System for rapid analysis of glycated proteinaceous species in biological samples
10/16/2008WO2008060540A3 Methods of identifying compositions that modulate the protein tyrosine phosphatase, ptp-bl
10/16/2008WO2008060483A3 Protein-protein interaction biosensors and methods of use thereof
10/16/2008WO2008059381A3 Methods for identifying anti-tumor and/or anti-angiogenesis drugs with rcl deoxynucleoside 5' -monophosphate n-glycosidase as the target
10/16/2008WO2008058004A3 Particles containing detectable elemental code
10/16/2008WO2008057437A3 Ex vivo flow cytometry method and device
10/16/2008WO2008055995A3 Methods and compositions for detecting receptor ligand mimetics
10/16/2008WO2008054770A3 Use of tumor necrosis factor-alpha p75 receptor for the reduction of inflammation
10/16/2008WO2008046665A3 Method for identifying urotensin 2 convertase inhibitors
10/16/2008WO2008033858A3 Kinase inhibitors, and methods of using and identifying kinase inhibitors
10/16/2008WO2008030381A3 Methods for ranking cellular images
10/16/2008WO2008013953A3 Tyrosine phosphorylation sites
10/16/2008WO2008008982A3 Modified annexin proteins and methods for their use in platelet storage and transfusion
10/16/2008WO2008005561A3 Mechanism to signal receptor-ligand interactions with luminescent quantum dots
10/16/2008WO2008005464A3 Quantifiable internal reference standards for immunohistochemistry and uses thereof
10/16/2008WO2007146702A3 Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels
10/16/2008WO2007146104A3 Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
10/16/2008WO2007146003A3 Methods for ester detoxication
10/16/2008WO2007143574A8 Protein surface remodeling
10/16/2008WO2007137072A3 Assays for diagnosing and evaluating treatment options for fabry disease
10/16/2008WO2007134167A3 Computational analysis of the synergy among multiple interacting factors
10/16/2008WO2007130950A3 Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties
10/16/2008WO2007123880B1 Methods and kits for early stage caries detection
10/16/2008WO2007117553A3 Method of controlling insect pests in cotton
10/16/2008WO2007115230A3 A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells
10/16/2008WO2007112045A3 Use of somatostatin agonists to treat medullary thyroid carcinoma
10/16/2008WO2007106577A3 Gelsolin in the treatment and diagnosis of neurological disease
10/16/2008WO2007106425A3 Biomarkers of the dysplastic state of cells
10/16/2008WO2007102872A3 Compositions and methods related to controlled gene expression using viral vectors
10/16/2008WO2007098148A3 Mthods and arrays for target analyte detection and determination of target analyte concentration in solution
10/16/2008WO2007094924A3 Human telomerase reverse transcriptase peptides
10/16/2008WO2007092941A3 Sers nanotag assays
10/16/2008WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
10/16/2008WO2007028161A3 Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
1 ... 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 ... 3937